Ipca Laboratories Ltd.

NSE: IPCALAB | BSE: 524494 | ISIN: INE571A01038 | Industry: Pharmaceuticals
| Expensive Performer
1433.2500 -13.50 (-0.93%)
NSE Mar 26, 2025 15:50 PM
Volume: 153.1K
 

1433.25
-0.93%
Motilal Oswal
Following a muted performance in the US over the past eight years due to compliance issues, IPCA is well-poised to revive its US business through new product launches, relaunches, stable pricing in its base business, and the integration of the Unichem business over the next 12-24M.
Ipca Laboratories Ltd. has an average target of 1815.00 from 3 brokers.
More from Ipca Laboratories Ltd.
More from Suhani Adilabadkar
Recommended